Structure of the Autoinducer Required for Expression of Pseudomonas
Total Page:16
File Type:pdf, Size:1020Kb
Proc. Natl. Acad. Sci. USA Vol. 91, pp. 197-201, January 1994 Biochemistry Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes [density-dependent transcription/gene activation/las genes/N-acyl homoserine lactone/3-oxo-N-(tetrahydro-2-oxo-3- furanyl)dodecanamideJ JAMES P. PEARSON*, KENDALL M. GRAY*, LUCIANO PASSADORt, KENNETH D. TUCKERt, ANATOL EBERHARD*, BARBARA H. IGLEWSKIt, AND E. P. GREENBERG*§ *Department of Microbiology, University of Iowa, Iowa City, IA 52242; tDepartment of Microbiology and Immunology, University of Rochester, Rochester, NY 14642; and FDepartment of Chemistry, Ithaca College, Ithaca, NY 14850 Communicated by Ralph S. Wolfe, September 16, 1993 ABSTRACT In Pseudomonas aeruginosa the LasR protein a threshold level and luminescence gene transcription will be is required for activation of lasB and several other virulence activated. At low cell densities, autoinducer will diffuse out genes. A diffusible signal molecule, the P. aeruginosa autoin- of cells and be diluted into the surrounding medium, and the ducer (PAI), produced by the bacterial cel and released into luminescence genes will not be activated (ref. 15; for a recent the growth medium, is required for activity ofLasR. By cloning review, see ref. 16). a lasB::lacZ fusion and a lasR gene under control of the lac It has been reported that P. aeruginosa can synthesize VAI promoter in Escherichia coli, we have developed a quantitative (17) and that the P. aeruginosa autoinducer (PAI) might in bioassay for PAI. We have used this assay to foUlow the fact be VAI (18). In this report we show that the diffusible purification of PAI from cel-free culture supernatant fluids in compound produced by bacteria containing the lasIgene and which P. aeruginosa or E. coli containing the P. aeruginosa required for activity of the LasR protein is not identical to gene required for autoinducer synthesis, lasI, had been grown. VAI, N-(3-oxohexanoyl)homoserine lactone. Rather it is the Chemical analyses indicated the purified material was 3-oxo- related N-acyl-homoserine lactone, 3-oxo-N-(tetrahydro-2- N-(tetrahydro-2-oxo-3-furanyl)dodecanamide. To confirm this oxo-3-furanyl)dodecanamide [or N-(3-oxododecanoyl)homo- assignment, the compound was synthesized and the synthetic serine lactone]. compound was shown to have chemical and biological proper- ties identical to those of PAI purified from culture supernatant fluids. The elucidation of the PAI structure suggests therapeu- MATERIALS AND METHODS tic approaches toward control of P. aeruginosa infections. Bacterial Strains, Plasmids, and Culture Conditions. The E. coli strains used were TB1 (19), MG4 (20), and VJS533 (21). The Gram-negative bacterium Pseudomonas aeruginosa is The P. aeruginosa strains used were PAO1, which contains an opportunistic human pathogen that causes infections in functional lasR and lasI genes, and PAO-RI, which is a immunocompromised hosts and colonizes the lungs of indi- lasRlasI mutant derived from PAO1 (8). The plasmids viduals with cystic fibrosis (1, 2). This bacterium produces a used were pLasI-1, a lasI expression vector (11), pKDT17, number of extracellular virulence factors including exotoxin which contains a lasB::lacZ reporter of lasB promoter activ- A, encoded by the toxA gene (3, 4), two elastolytic proteases, ity and lasR under control of the lac promoter, and encoded by the lasA and lasB genes, and an alkaline protease, pHV200I-, which contains the V.fischeriluminescence gene encoded by the aprA gene (5-7). cluster with an inactive luxI. These plasmids are all ColEl The P. aeruginosa lasR gene encodes a transcriptional replicons containing an ampicillin-resistance marker. Con- activator, the LasR protein (8). Because the LasR protein struction of pKDT17 involved cloning into Sma T-digested activates transcription of aprA, lasA, and lasB and enhances pUCP18 (22), an 800-bp lasR fragment from pMJG1.7 (8) that toxA expression (8-10), this transcription factor is considered extended from the EcoRV site 59 bp upstream of the lasR to be a global regulator of P. aeruginosa virulence genes. transcriptional start to the Alu I site 22 bp beyond the lasR Activity ofLasR is dependent on a diffusible factor produced translational stop codon to construct pKDT11. In this plas- by P. aeruginosa containing a functional lasI gene or by mid, lasR is under control of the lac promoter. An interme- Escherichia coli containing a lasI gene cloned from P. diate construct containing only two Pvu II sites was made by aeruginosa (11). LasR and LasI, the lasI gene product, show subcloning the 800-bp fragment from pKDT11 into pUC18 to significant sequence identity with the LuxR and LuxI pro- form pKDT13. This intermediate construct was digested with teins ofthe luminescent marine bacterium, Vibriofischeri (8, Pvu II and the plac-lasR fragment was cloned in Tth III- 11). LuxR is a transcriptional activator of the luminescence digested pTS400. The plasmid pTS400 contains a lasB::lacZ genes, and activity of LuxR is dependent on a diffusible translational fusion (11, 23). The resulting plasmid was called substance, termed the autoinducer, that is synthesized by pKDT17. The plasmid pHV200T- was derived from the lux cells containing a functional luxIgene (12, 13). The V.flscheri regulon-containing pHV200 (24) by introducing a frameshift autoinducer (VAI) is 3-oxo-N-(tetrahydro-2-oxo-3-furanyl)- mutation in luxi. This was accomplished by digesting hexanamide, commonly termed N-(3-oxohexanoyl)homo- pHV200 with Bgl TT, filling-in the single-stranded overhangs serine lactone (14). Because cells of V. fischeri are freely with Taq polymerase, and treating the product with T4 DNA permeable to it, VAI accumulates in the medium during ligase. growth. Thus the response of LuxR to autoinducer defines a For production of PAI, cultures ofP. aeruginosa PA01 or cell-density-dependent system for gene regulation. At high E. coli TB1 containing pLasT-l were grown to late- cell densities, autoinducer concentrations will increase above Abbreviations: PAI, Pseudomonas aeruginosa autoinducer; VAI, The publication costs of this article were defrayed in part by page charge Vibrio fischeri autoinducer; AAI, Agrobacterium tumefaciens au- payment. This article must therefore be hereby marked "advertisement" toinducer. in accordance with 18 U.S.C. §1734 solely to indicate this fact. §To whom reprint requests should be addressed. 197 Downloaded by guest on October 2, 2021 198 Biochemistry: Pearson et aL Proc. Natl. Acad. Sci. USA 91 (1994) exponential phase in A medium (25) supplemented with 0.4% N-(3-oxohexanoyl)homoserine lactone. The major difference glucose, 0.05% yeast extract, and 1 mM MgSO4 with shaking was that ethyl 3-oxododecanoate was used instead of ethyl at 37°C. For use in autoinducer bioassays, E. coli MG4 3-oxohexanoate. The ethyl 3-oxododecanoate was prepared containing pKDT17 was grown in supplemented A medium at from decanoyl chloride and the dilithio dianion of monoethyl 30°C with shaking, and E. coli VJS533 containing pHV200I- hydrogen malonate (31). The ethylene glycol ketal of ethyl was grown in L broth (26) at 30°C with shaking. For plasmid 3-oxododecanoate was prepared as described for ethyl 3-oxo- screening and maintenance, ampicillin (100 ,ug/ml) was in- hexanoate (14) except that Dowex-50 sulfonic acid cation- cluded in E. coli cultures. exchange resin was used in place ofp-toluenesulfonic acid as Plasmid Purification and Transformation Procedure. Plas- described by Goswami et al. (32). The sodium salt was mids were purified and manipulated as described (25). The prepared (14) and incubated with equimolar amounts of transformation procedure used was described by Hanahan L-homoserine lactone hydrochloride (Sigma) and 1-(3- (27). dimethylaminopropyl)-3-ethylcarbodiimide (Aldrich, Mil- Autoinducer Bioassays. When grown in a medium condi- waukee, Wisconsin). The resulting ethylene glycol ketal of tioned by the growth ofa recombinant E. coli containing lasI, N-(3-oxododecanoyl)-L-homoserine lactone was deprotected E. coli MG4 containing a plasmid with lasR and a lasB::lacZ by acid treatment (14) to yield N-(3-oxododecanoyl)-L- transcriptional fusion shows a 25-fold induction of ,B-galac- homoserine lactone. This compound was purified by HPLC tosidase (11). This formed the basis of our quantitative PAI and stored as described above. assay. We found that PAI activity could be extracted in ethyl Spectra. Proton NMR was performed on a Varian Unity acetate as described for VAI (14, 28). For our bioassays, 500-MHz instrument. Infrared spectroscopy ofintermediates overnight cultures ofE. coli containing pKDT17 were diluted in the synthesis of PAI was performed on a Nicolet 205 in supplemented A medium to an ODw0 of 0.1 and stored on Fourier transform infrared spectrometer. Chemical ioniza- ice. Each bioassay consisted of 2 ml of the cell suspension tion mass spectrometry was performed on a Nermag R1-10C plus the test sample. After 5.5 h at 30°C, ,3-galactosidase probe. The activity was measured as described by Miller (29). Without instrument with a desorption chemical ionization addition of autoinducer, ,B-galactosidase activities were 25 ± reagent gas was ammonia. High-resolution fast atom bom- 10 Miller units and, with saturating amounts of autoinducer, bardment was performed at the University of Nebraska, ,B-galactosidase activities were 1500 ± 200 Miller units. A unit Midwest Center for Mass Spectrometry. of PAI activity is defined as that amount required to achieve 50%o saturation in the bioassay. RESULTS The assay for VAI was based on those described elsewhere (15, 17, 28). Because luminescence of E. coli containing Purification of PAI from Culture Media. Ethyl acetate pHV200I- requires the addition of VAI, this recombinant extracts of media from cultures of E. coli (pLasI-1) or P. strain was-used to test for VAI activity. Overnight cultures of aeruginosa PA01 contained PAI activity in amounts equiv- E. coli containing pHV200I- were diluted to an OD6,w of0.01 alent to those in the culture media prior to extraction.